PDSB
PDS Biotechnology Corporation
Halal Rating :
Last Price
$1.46
Last updated:
Market Cap
-
7D Change
2.82%
1 Year Change
-67.48%
Company Overview
Industries
Exchange
Next Earnings Date
PDS Biotechnology Corporation is a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on their proprietary Versamune® platform technology. The company focuses on developing treatments for various types of cancers, with their lead product candidate being PDS0101 for HPV-associated cancers.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate PDS Biotechnology Corporation's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.